IMP
Process View
glomerulus vasculature development
The biological process whose specific outcome is the progression of a glomerulus vasculature from an initial condition to its mature state. This process begins with the formation of the glomerulus vasculature and ends with the mature structure. The glomerulus vasculature is composed of the tubule structures that carry blood or lymph in the glomerulus.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "glomerulus vasculature development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| JAG1 | jagged 1 | 0.995 | ||
| ACTB | actin, beta | 0.966 | Human | |
| CFL1 | cofilin 1 (non-muscle) | 0.948 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.923 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.855 | Mouse | |
| VEGFA | vascular endothelial growth factor A | 0.739 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.648 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.581 | ||
| NOTCH1 | notch 1 | 0.448 | Mouse | |
| ACTG1 | actin, gamma 1 | 0.395 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.379 | Mouse | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.319 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.223 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.223 | ||
| TUBA1C | tubulin, alpha 1c | 0.221 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.196 | Human | |
| NRP1 | neuropilin 1 | 0.155 | ||
| NOTCH3 | notch 3 | 0.151 | Mouse | |
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.132 | ||
| TUBA1B | tubulin, alpha 1b | 0.119 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.113 | ||
| CFL2 | cofilin 2 (muscle) | 0.093 | ||
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.086 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.076 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.075 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.069 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.055 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.049 | ||
| NOG | noggin | 0.045 | ||
| BMP4 | bone morphogenetic protein 4 | 0.043 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.042 | ||
| IER2 | immediate early response 2 | 0.032 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.030 | ||
| PGF | placental growth factor | 0.029 | Human | |
| TRIM63 | tripartite motif containing 63 | 0.029 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.028 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.027 | ||
| EGR2 | early growth response 2 | 0.026 | ||
| EGR3 | early growth response 3 | 0.023 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.021 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.021 | ||
| PDGFC | platelet derived growth factor C | 0.020 | ||
| MAML1 | mastermind-like 1 (Drosophila) | 0.019 | ||
| JAG2 | jagged 2 | 0.016 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.015 | ||
| ANGPT2 | angiopoietin 2 | 0.015 | ||
| PPIA | peptidylprolyl isomerase A (cyclophilin A) | 0.014 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.014 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.013 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.013 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.012 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.011 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.010 |